nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—Estriol—ESR2—coronary artery disease	0.00693	0.144	CrCbGaD
Equilin—Estropipate—ESR2—coronary artery disease	0.0053	0.11	CrCbGaD
Equilin—Estriol—ESR1—coronary artery disease	0.00427	0.0889	CrCbGaD
Equilin—Ethinyl Estradiol—ESR2—coronary artery disease	0.00378	0.0788	CrCbGaD
Equilin—Conjugated Estrogens—ESR2—coronary artery disease	0.00331	0.0689	CrCbGaD
Equilin—Estrone—ESR2—coronary artery disease	0.0033	0.0687	CrCbGaD
Equilin—Estropipate—ESR1—coronary artery disease	0.00326	0.068	CrCbGaD
Equilin—Estradiol—SLC22A3—coronary artery disease	0.00314	0.0653	CrCbGaD
Equilin—Estradiol—ESR2—coronary artery disease	0.0025	0.0521	CrCbGaD
Equilin—Ethinyl Estradiol—ESR1—coronary artery disease	0.00233	0.0486	CrCbGaD
Equilin—Conjugated Estrogens—ESR1—coronary artery disease	0.00204	0.0424	CrCbGaD
Equilin—Estrone—ESR1—coronary artery disease	0.00203	0.0423	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—MDK—coronary artery disease	0.002	0.0021	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RAMP2—coronary artery disease	0.002	0.0021	CbGpPWpGaD
Equilin—HSD17B1—Disease—HDAC9—coronary artery disease	0.00199	0.0021	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	0.00197	0.00207	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP11B2—coronary artery disease	0.00196	0.00206	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—TXNRD1—coronary artery disease	0.00196	0.00206	CbGpPWpGaD
Equilin—HSD17B1—Disease—P4HB—coronary artery disease	0.00194	0.00203	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC22A3—coronary artery disease	0.00194	0.00203	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ARNTL—coronary artery disease	0.00191	0.002	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HADH—coronary artery disease	0.00191	0.002	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2RL1—coronary artery disease	0.0019	0.002	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY5R—coronary artery disease	0.0019	0.002	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RALBP1—coronary artery disease	0.0019	0.002	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP3R1—coronary artery disease	0.0019	0.002	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	0.00188	0.00197	CbGpPWpGaD
Equilin—HSD17B1—Disease—CYBB—coronary artery disease	0.00184	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Disease—NPPA—coronary artery disease	0.00184	0.00193	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	0.00183	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FZD2—coronary artery disease	0.00182	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—UTS2R—coronary artery disease	0.00182	0.00192	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G2A—coronary artery disease	0.00181	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA2—coronary artery disease	0.00181	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX2—coronary artery disease	0.00181	0.0019	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAP2K3—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Disease—VCAN—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SFRP2—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SULT1A1—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCG5—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HK1—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX4—coronary artery disease	0.00179	0.00188	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	0.00178	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Disease—ALDOA—coronary artery disease	0.00178	0.00187	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HADHA—coronary artery disease	0.00176	0.00185	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADORA1—coronary artery disease	0.00176	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADORA3—coronary artery disease	0.00176	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOA4—coronary artery disease	0.00176	0.00184	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTA1—coronary artery disease	0.00174	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Disease—CST3—coronary artery disease	0.00174	0.00183	CbGpPWpGaD
Equilin—HSD17B1—Disease—DCN—coronary artery disease	0.00173	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPA—coronary artery disease	0.00172	0.00181	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPBP—coronary artery disease	0.0017	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PGF—coronary artery disease	0.0017	0.00178	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLCB3—coronary artery disease	0.00167	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DVL1—coronary artery disease	0.00167	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ITGA2B—coronary artery disease	0.00167	0.00175	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA5—coronary artery disease	0.00165	0.00174	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOC3—coronary artery disease	0.00163	0.00171	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—P4HB—coronary artery disease	0.00162	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GHR—coronary artery disease	0.00162	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL4—coronary artery disease	0.00162	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—OPRD1—coronary artery disease	0.00162	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Disease—LDLR—coronary artery disease	0.00162	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	0.00161	0.00169	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC9A1—coronary artery disease	0.0016	0.00168	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLA2G1B—coronary artery disease	0.00159	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	0.00157	0.00165	CbGpPWpGaD
Equilin—HSD17B1—Disease—SDC1—coronary artery disease	0.00156	0.00164	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	0.00156	0.00163	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TLE4—coronary artery disease	0.00155	0.00163	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MEF2A—coronary artery disease	0.00155	0.00163	CbGpPWpGaD
Equilin—Estradiol—ESR1—coronary artery disease	0.00154	0.0321	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—APOA2—coronary artery disease	0.00151	0.00159	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—VCAN—coronary artery disease	0.0015	0.00158	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AVPR1A—coronary artery disease	0.00149	0.00157	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALDOA—coronary artery disease	0.00149	0.00156	CbGpPWpGaD
Equilin—HSD17B1—Disease—PSMB5—coronary artery disease	0.00147	0.00155	CbGpPWpGaD
Equilin—HSD17B1—Disease—PSMA6—coronary artery disease	0.00147	0.00155	CbGpPWpGaD
Equilin—Estropipate—ALB—coronary artery disease	0.00145	0.0303	CrCbGaD
Equilin—HSD17B1—Metabolism—DCN—coronary artery disease	0.00145	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—UTS2—coronary artery disease	0.00144	0.00152	CbGpPWpGaD
Equilin—HSD17B1—Disease—GOT2—coronary artery disease	0.00143	0.0015	CbGpPWpGaD
Equilin—HSD17B1—Disease—CYBA—coronary artery disease	0.00142	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Disease—CALR—coronary artery disease	0.00142	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NR4A1—coronary artery disease	0.00141	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALDH2—coronary artery disease	0.00141	0.00148	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLCB3—coronary artery disease	0.0014	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HDAC9—coronary artery disease	0.0014	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—P2RY12—coronary artery disease	0.0014	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CX3CR1—coronary artery disease	0.00138	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASR—coronary artery disease	0.00138	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	0.00137	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LIPC—coronary artery disease	0.00137	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HBA1—coronary artery disease	0.00137	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3C2A—coronary artery disease	0.00137	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2C19—coronary artery disease	0.00137	0.00144	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOC3—coronary artery disease	0.00136	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNA12—coronary artery disease	0.00136	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CX3CL1—coronary artery disease	0.00136	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BDKRB1—coronary artery disease	0.00136	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—P4HB—coronary artery disease	0.00136	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LDLR—coronary artery disease	0.00135	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	0.00135	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTT1—coronary artery disease	0.00134	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC9A1—coronary artery disease	0.00134	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP3R1—coronary artery disease	0.00133	0.0014	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCLC—coronary artery disease	0.00132	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CETP—coronary artery disease	0.00132	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADM—coronary artery disease	0.00132	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Disease—HSPA1A—coronary artery disease	0.00132	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Disease—JUNB—coronary artery disease	0.00132	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SDC1—coronary artery disease	0.00131	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PDE4B—coronary artery disease	0.00129	0.00135	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CYBB—coronary artery disease	0.00129	0.00135	CbGpPWpGaD
Equilin—Estradiol—CYP2C19—coronary artery disease	0.00124	0.0257	CrCbGaD
Equilin—HSD17B1—Metabolism—PSMA6—coronary artery disease	0.00124	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PSMB5—coronary artery disease	0.00124	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	0.00123	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Disease—GOT1—coronary artery disease	0.00123	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CTGF—coronary artery disease	0.00121	0.00127	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMGCR—coronary artery disease	0.0012	0.00126	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GOT2—coronary artery disease	0.0012	0.00126	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCR3—coronary artery disease	0.00118	0.00124	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CRK—coronary artery disease	0.00116	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SH2B3—coronary artery disease	0.00115	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VWF—coronary artery disease	0.00115	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ATP2A2—coronary artery disease	0.00115	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOC3—coronary artery disease	0.00114	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCE—coronary artery disease	0.00114	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LDLR—coronary artery disease	0.00113	0.00119	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFBR2—coronary artery disease	0.00111	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Disease—KITLG—coronary artery disease	0.00111	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL2—coronary artery disease	0.00111	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL3—coronary artery disease	0.00111	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PLCB1—coronary artery disease	0.0011	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SDC1—coronary artery disease	0.00109	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2R—coronary artery disease	0.00109	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT5A—coronary artery disease	0.00108	0.00114	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	0.00108	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGB—coronary artery disease	0.00107	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ABCA1—coronary artery disease	0.00107	0.00112	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDNRB—coronary artery disease	0.00106	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOB—coronary artery disease	0.00105	0.0011	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—THBS1—coronary artery disease	0.00104	0.0011	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PSMB5—coronary artery disease	0.00103	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PSMA6—coronary artery disease	0.00103	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GGT1—coronary artery disease	0.00103	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GOT1—coronary artery disease	0.00103	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF1—coronary artery disease	0.00101	0.00106	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDNRA—coronary artery disease	0.001	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Disease—LPL—coronary artery disease	0.000999	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CYBA—coronary artery disease	0.000995	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB1—coronary artery disease	0.000995	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DUSP6—coronary artery disease	0.000991	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLAT—coronary artery disease	0.000974	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL12—coronary artery disease	0.00094	0.000987	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BDKRB2—coronary artery disease	0.00094	0.000987	CbGpPWpGaD
Equilin—HSD17B1—Disease—PPP2CA—coronary artery disease	0.000937	0.000984	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTP1—coronary artery disease	0.000927	0.000974	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JUNB—coronary artery disease	0.000923	0.000969	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCD—coronary artery disease	0.00092	0.000966	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLCB1—coronary artery disease	0.000919	0.000966	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARGC1A—coronary artery disease	0.000919	0.000965	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMOX1—coronary artery disease	0.000914	0.00096	CbGpPWpGaD
Equilin—Estrone—ALB—coronary artery disease	0.000904	0.0188	CrCbGaD
Equilin—HSD17B1—Metabolism—CAT—coronary artery disease	0.000902	0.000948	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR7—coronary artery disease	0.0009	0.000946	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—coronary artery disease	0.000899	0.000944	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOB—coronary artery disease	0.000876	0.00092	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ITGAV—coronary artery disease	0.000858	0.000901	CbGpPWpGaD
Equilin—HSD17B1—Disease—HIF1A—coronary artery disease	0.000857	0.000901	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KNG1—coronary artery disease	0.000855	0.000898	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GSTM1—coronary artery disease	0.000852	0.000895	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGTR1—coronary artery disease	0.00085	0.000893	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOE—coronary artery disease	0.000837	0.000879	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPL—coronary artery disease	0.000836	0.000878	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL10—coronary artery disease	0.000831	0.000873	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLG—coronary artery disease	0.000828	0.00087	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOA1—coronary artery disease	0.000827	0.000869	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX1—coronary artery disease	0.000816	0.000857	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB2—coronary artery disease	0.000806	0.000847	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCE—coronary artery disease	0.000796	0.000836	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CD36—coronary artery disease	0.000795	0.000835	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS1—coronary artery disease	0.000794	0.000834	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—S100B—coronary artery disease	0.000792	0.000832	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6ST—coronary artery disease	0.000786	0.000826	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPP2CA—coronary artery disease	0.000785	0.000824	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS3—coronary artery disease	0.000785	0.000824	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS2—coronary artery disease	0.00078	0.000819	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KITLG—coronary artery disease	0.000775	0.000814	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFBR2—coronary artery disease	0.000775	0.000814	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT5A—coronary artery disease	0.000758	0.000796	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP3—coronary artery disease	0.000758	0.000796	CbGpPWpGaD
Equilin—HSD17B1—Disease—KIT—coronary artery disease	0.000755	0.000793	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—coronary artery disease	0.000753	0.000791	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOB—coronary artery disease	0.000732	0.000769	CbGpPWpGaD
Equilin—HSD17B1—Disease—GSK3B—coronary artery disease	0.000725	0.000761	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—EDN1—coronary artery disease	0.000721	0.000757	CbGpPWpGaD
Equilin—HSD17B1—Disease—CREB1—coronary artery disease	0.000719	0.000755	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AGT—coronary artery disease	0.000715	0.000751	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL5—coronary artery disease	0.000715	0.000751	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CSF2—coronary artery disease	0.000704	0.00074	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF1—coronary artery disease	0.000704	0.00074	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6R—coronary artery disease	0.000701	0.000737	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOE—coronary artery disease	0.000701	0.000736	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPL—coronary artery disease	0.000699	0.000734	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MEF2C—coronary artery disease	0.000693	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RPS6KB1—coronary artery disease	0.000693	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA1—coronary artery disease	0.000693	0.000728	CbGpPWpGaD
Equilin—Estradiol—ALB—coronary artery disease	0.000685	0.0143	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—ITGB3—coronary artery disease	0.000675	0.000709	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	0.000664	0.000697	CbGpPWpGaD
Equilin—HSD17B1—Disease—SERPINE1—coronary artery disease	0.000657	0.00069	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPP2CA—coronary artery disease	0.000656	0.000689	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCD—coronary artery disease	0.000644	0.000677	CbGpPWpGaD
Equilin—HSD17B1—Disease—FGF2—coronary artery disease	0.000636	0.000668	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2A—coronary artery disease	0.00063	0.000662	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—C3—coronary artery disease	0.00063	0.000661	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—coronary artery disease	0.000627	0.000659	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—coronary artery disease	0.000611	0.000641	CbGpPWpGaD
Equilin—HSD17B1—Disease—JAK2—coronary artery disease	0.000609	0.00064	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—POMC—coronary artery disease	0.000602	0.000633	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HIF1A—coronary artery disease	0.0006	0.000631	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGT—coronary artery disease	0.000598	0.000628	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOE—coronary artery disease	0.000586	0.000616	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—coronary artery disease	0.000586	0.000616	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOA1—coronary artery disease	0.000579	0.000609	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KDR—coronary artery disease	0.000574	0.000603	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—coronary artery disease	0.000574	0.000602	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK14—coronary artery disease	0.00057	0.000599	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—coronary artery disease	0.00056	0.000588	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2—coronary artery disease	0.000553	0.000581	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FN1—coronary artery disease	0.000553	0.000581	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6ST—coronary artery disease	0.000551	0.000578	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—coronary artery disease	0.000549	0.000577	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NFKBIA—coronary artery disease	0.000546	0.000574	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—KIT—coronary artery disease	0.000529	0.000556	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—coronary artery disease	0.000525	0.000552	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GSK3B—coronary artery disease	0.000508	0.000533	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—POMC—coronary artery disease	0.000504	0.000529	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CREB1—coronary artery disease	0.000504	0.000529	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—coronary artery disease	0.000493	0.000517	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6R—coronary artery disease	0.000491	0.000516	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—coronary artery disease	0.000484	0.000509	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PTGS2—coronary artery disease	0.00048	0.000505	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—coronary artery disease	0.00046	0.000483	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FGF2—coronary artery disease	0.000445	0.000468	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—coronary artery disease	0.000439	0.000461	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—JAK2—coronary artery disease	0.000427	0.000448	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—coronary artery disease	0.000415	0.000436	CbGpPWpGaD
Equilin—HSD17B1—Disease—MAPK1—coronary artery disease	0.000407	0.000427	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CXCL8—coronary artery disease	0.000389	0.000409	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CASP3—coronary artery disease	0.000373	0.000392	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCND1—coronary artery disease	0.000363	0.000381	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—coronary artery disease	0.000353	0.000371	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—coronary artery disease	0.000352	0.00037	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—VEGFA—coronary artery disease	0.000316	0.000332	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—coronary artery disease	0.000312	0.000328	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—coronary artery disease	0.000295	0.00031	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—coronary artery disease	0.00029	0.000305	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—coronary artery disease	0.000288	0.000303	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK1—coronary artery disease	0.000285	0.000299	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—coronary artery disease	0.000247	0.00026	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—coronary artery disease	0.000241	0.000254	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—coronary artery disease	0.000219	0.00023	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—coronary artery disease	0.000202	0.000212	CbGpPWpGaD
